Literature DB >> 25034274

Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.

Masaki Kobayashi1, Yuko Shimizu, Noriyuki Shibata, Shinichiro Uchiyama.   

Abstract

Tumefactive demyelinating lesions (TDLs) can mimic brain tumors on radiological images. TDLs are often referred to as tumefactive multiple sclerosis (TMS), but the heterogeneous nature and monophasic course of TDLs do not fulfill clinical and magnetic resonance imaging (MRI) criteria for multiple sclerosis. Redefining TDLs, TMS and other inflammatory brain lesions is essential for the accurate clinical diagnosis of extensive demyelinating brain lesions. We retrospectively analyzed MRI from nine TDL cases that underwent brain biopsy. Patterns of gadolinium enhancement on MRI were categorized as homogenous, inhomogeneous, patchy and diffuse, open ring or irregular rim, and were compared with pathological hallmarks including demyelination, central necrosis, macrophage infiltration, angiogenesis and perivascular lymphocytic cuffing. All cases had coexistence of demyelinating features and axonal loss. Open-ring and irregular rim patterns of gadolinium enhancement were associated with macrophage infiltrations and angiogenesis at the inflammatory border. An inhomogeneous pattern of gadolinium enhancement was associated with perivascular lymphocytic cuffing. Central necrosis was seen in cases of severe multiple sclerosis and hemorrhagic leukoencephalopathy. These results suggest that the radiological features of TDLs may be related to different pathological processes, and indicate that MRI may be useful in understanding their pathophysiology. Further investigation is needed to determine the precise disease entity of these inflammatory demyelinating brain lesions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25034274     DOI: 10.1007/s00415-014-7437-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

Review 1.  The spectrum of multiple sclerosis and treatment decisions.

Authors:  Aksel Siva
Journal:  Clin Neurol Neurosurg       Date:  2005-12-27       Impact factor: 1.876

2.  Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings.

Authors:  Jen Jen Su; Manabu Osoegawa; Takeshi Matsuoka; Motozumi Minohara; Masahito Tanaka; Takaaki Ishizu; Futoshi Mihara; Takayuki Taniwaki; Jun-ichi Kira
Journal:  J Neurol Sci       Date:  2005-12-27       Impact factor: 3.181

3.  In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema.

Authors:  S P Morrissey; H Stodal; U Zettl; C Simonis; S Jung; R Kiefer; H Lassmann; H P Hartung; A Haase; K V Toyka
Journal:  Brain       Date:  1996-02       Impact factor: 13.501

4.  Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.

Authors:  Takao Kiriyama; Hiroshi Kataoka; Toshiaki Taoka; Yasuyo Tonomura; Mari Terashima; Masami Morikawa; Emi Tanizawa; Makoto Kawahara; Yoshiko Furiya; Kazuma Sugie; Kimihiko Kichikawa; Satoshi Ueno
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

5.  Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.

Authors:  Toshiyuki Takahashi; Kazuo Fujihara; Ichiro Nakashima; Tatsuro Misu; Isabelle Miyazawa; Masashi Nakamura; Shohei Watanabe; Naoto Ishii; Yasuto Itoyama
Journal:  Tohoku J Exp Med       Date:  2006-12       Impact factor: 1.848

6.  Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy.

Authors:  G M Nesbit; G S Forbes; B W Scheithauer; H Okazaki; M Rodriguez
Journal:  Radiology       Date:  1991-08       Impact factor: 11.105

7.  Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.

Authors:  Mirja Wallner-Blazek; Alex Rovira; Massimo Fillipp; Mara A Rocca; David H Miller; Klaus Schmierer; Jette Frederiksen; Achim Gass; Hugo Gama; Charles P Tilbery; Antonio J Rocha; José Flores; Frederik Barkhof; Alexandra Seewann; Jacqueline Palace; Tarek Yousry; Xavier Montalban; Christian Enzinger; Franz Fazekas
Journal:  J Neurol       Date:  2013-04-26       Impact factor: 4.849

8.  Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis.

Authors:  Nathan P Young; Brian G Weinshenker; Joseph E Parisi; B Scheithauer; C Giannini; Shanu F Roemer; Kristine M Thomsen; Jayawant N Mandrekar; Bradley J Erickson; Claudia F Lucchinetti
Journal:  Brain       Date:  2010-02-03       Impact factor: 13.501

Review 9.  Imaging of acute disseminated encephalomyelitis.

Authors:  Andrea Rossi
Journal:  Neuroimaging Clin N Am       Date:  2008-02       Impact factor: 2.264

10.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

View more
  8 in total

Review 1.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

2.  Contralateral recurrence of tumefactive demyelination.

Authors:  Mohammed Nazir Khan; Mihail Guranda; Marco Essig
Journal:  Neuroradiol J       Date:  2015-10-01

3.  Custom fit 3D-printed brain holders for comparison of histology with MRI in marmosets.

Authors:  Joseph R Guy; Pascal Sati; Emily Leibovitch; Steven Jacobson; Afonso C Silva; Daniel S Reich
Journal:  J Neurosci Methods       Date:  2015-09-10       Impact factor: 2.390

4.  Evaluation of Diagnostic Accuracy Following the Coadministration of Delta-Aminolevulinic Acid and Second Window Indocyanine Green in Rodent and Human Glioblastomas.

Authors:  Steve S Cho; Saad Sheikh; Clare W Teng; Joseph Georges; Andrew I Yang; Emma De Ravin; Love Buch; Carrie Li; Yash Singh; Denah Appelt; Edward J Delikatny; E James Petersson; Andrew Tsourkas; Jay Dorsey; Sunil Singhal; John Y K Lee
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

Review 5.  Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.

Authors:  Meredith C Frederick; Michelle H Cameron
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

Review 6.  Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.

Authors:  Aigli G Vakrakou; Maria-Evgenia Brinia; Ioanna Svolaki; Theodore Argyrakos; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

7.  Transtentorial herniation from tumefactive multiple sclerosis mimicking primary brain tumor.

Authors:  Kunal Vakharia; Haris Kamal; Gursant S Atwal; James L Budny
Journal:  Surg Neurol Int       Date:  2018-10-17

Review 8.  Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers.

Authors:  Matteo Bauckneht; Selene Capitanio; Stefano Raffa; Luca Roccatagliata; Matteo Pardini; Caterina Lapucci; Cecilia Marini; Gianmario Sambuceti; Matilde Inglese; Paolo Gallo; Diego Cecchin; Flavio Nobili; Silvia Morbelli
Journal:  EJNMMI Radiopharm Chem       Date:  2019-04-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.